To include your compound in the COVID-19 Resource Center, submit it here.

Priority Review for Nicox's eye drop

Nicox S.A. (Euronext:COX) said FDA accepted and granted

Read the full 85 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE